Novo Nordisk today announced that the Japanese Ministry of Health, Labour and Welfare has approved Tresiba® (insulin degludec) for the treatment of diabetes. Tresiba® is a new generation of once-daily ...
Novo Nordisk announced that the Food and Drug Administration (FDA) has approved an expanded use for Tresiba (insulin degludec) injection to improve glycemic control in children and adolescents with ...
Bagsværd, Denmark, 29 January 2016 - Novo Nordisk today announced the headline results from SWITCH 2, the first of two 2x32-weeks randomised, double-blind, cross-over, treat-to-target trials, ...
The primary endpoint was defined as the first occurrence of CV death, non-fatal myocardial infarction or non-fatal stroke Novo Nordisk announced top data from the DEVOTE trial confirming the ...
Adults with type 2 diabetes treated with Tresiba ® (insulin degludec injection)had asignificantreduction inHbA 1c and a 30% lower rate ...
SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- and long-acting insulins.
Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for Tresiba ® (insulin degludec injection), a ...
The study was conducted to evaluate the efficacy and safety of Tresiba (once daily) plus bolus insulin aspart in comparison with the company’s Levemir (insulin detemir) plus bolus insulin aspart. At ...
Novo Nordisk's new long-acting insulin, Tresiba, has been shown to be effective and safe for long-term use in children and young adults with type 1 diabetes, according to new data from a late-stage ...
The FINANCIAL — Novo Nordisk on September 27 announced that the China Food and Drug Administration (CFDA) has approved Tresiba (insulin degludec) for the treatment of diabetes in China. Tresiba is a ...
Tresiba (insulin degludec) is a prescription drug that’s used to manage high blood sugar in people with diabetes. Tresiba’s cost may depend on your dosage, your health insurance, and the pharmacy you ...